IANS
18 Feb 2016, 15:51 GMT+10
New York, Feb 18 (IANS) A new treatment for Middle East Respiratory Syndrome (MERS) has been found to protect mice from infection, according to a study.
MERS, a disease that can cause severe respiratory symptoms and has a death rate of 40 percent, has killed nearly 600 people since it was first discovered four years ago in Saudi Arabia.
The treatment - an antibody that blocks the MERS virus - was produced by cows that had been genetically modified to mimic certain aspects of the human immune system.
These cows were given a new MERS vaccine that led to production of anti-MERS antibodies in large quantities.
These antibodies were then purified to produce the therapeutic that was tested in the MERS-infected mice.
"These results are very promising," said one of the lead researchers on the study Matthew Frieman, associate professor of microbiology and immunology at the University of Maryland School of Medicine in the US.
"This is important not only because it gives us a potential way to attack MERS, but also because it provides evidence that using these transgenic cows can rapidly produce therapeutics," Frieman noted.
SAB, a biopharmaceutical company based in South Dakota, US provided the genetically modified cows, a technology that it invented.
Novavax, a vaccine biotech company based in Maryland in the US, provided the vaccine that triggered the antibody production in the cows.
The next step, which will occur in the next three to six months, will be a human clinical trial to test the safety of the therapeutic. If that works, a Phase 2 trial will follow to test whether it is effective for use in humans, in emergency situations, the researchers said.Get a daily dose of Israel Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Israel Herald.
More InformationCONCORD, New Hampshire: A federal judge in New Hampshire issued a crucial ruling on July 10 against President Donald Trump's executive...
DUBAI, U.A.E.: A cargo ship flagged under Liberia, known as the Eternity C, sank in the Red Sea following an attack executed by Yemen's...
WASHINGTON, D.C.: The Trump administration has started sending some weapons to Ukraine again, just a week after the Pentagon told officials...
ECAULT BEACH, France: On clear days, the white cliffs of the United Kingdom, are visible from northern France, where men, women, and...
ATLANTA, Georgia: The United States is facing its worst measles outbreak in more than three decades, with 1,288 confirmed cases so...
In the past month alone, 23 Israeli soldiers have been killed in Gaza—three more than the number of remaining living hostages held...
BATTLE CREEK, Michigan: In a major consolidation of iconic food brands, WK Kellogg has agreed to be acquired by the owner of Ferrero...
WASHINGTON, D.C.: Filmmaker Peter Jackson's lifelong fascination with the extinct giant New Zealand flightless bird called the moa...
NEW DELHI, India: India has submitted a revised proposal to the World Trade Organization (WTO) in Geneva to implement retaliatory tariffs...
SAN FRANCISCO, California: Nvidia, the Silicon Valley chipmaker at the heart of the artificial intelligence boom, this week briefly...
REDMOND, Washington: Artificial intelligence is transforming Microsoft's bottom line. The company saved over US$500 million last year...
WASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...